By Joanne Hatfield, PharmD, BCPS on Sep 17, 2025 4:57:51 PM
This quarter, the NIC was joined by NIC members from ChristianaCare and Stony Brook Medicine to share how their organizations used different strategies to increase DERS compliance.
| Recording Coming Soon |
Originally aired Wednesday, September 17, 2025
Dose error reduction software (DERS) compliance is a key indicator of how often infusions are programmed within the drug library of smart infusion pumps. Best practice guidelines recommend a goal DERS compliance of 95% or greater to ensure the safest delivery of intravenous medications to patients.
ChristianaCare and Stony Brook Medical Center have been successful in improving their DERS compliance through a combination of novel mechanisms and multidisciplinary engagement.
This quarter, the NIC will be joined by Maha O. Kebir, PharmD, MS, BCPS, CPHQ, CPPS, and Dean A. Bennett, RPh, CPHQ, LSSGB from ChristianaCare to share their use of RFID technology to drive improvement in DERS compliance. In addition, Randi Trope, DO, MBA, CMSO, FAAP from Stony Brook Medicine will share how her organization used unit-specific identifiers to increase DERS compliance.
Slides:
Slides Coming Soon
Featured Speakers
|
Randi Trope, DO, MBA, CMSO, FAAP Vice-Chair, Pediatric Quality and Safety |
Maha O. Kebir, PharmD, MS, BCPS, CPHQ, CPPS Clinical Pharmacist Specialist and Quality and Performance Improvement |
Dean A. Bennett, RPh, CPHQ, LSSGB Medication Safety Officer, Clinical Effectiveness Administration |
Hosts
|
Sean O'Neill, Pharm.D Co-Chair, National Infusion Collaborative Co-Founder, Bainbridge Health |
Joanne Hatfield, Pharm.D, BCPS Co-Chair, National Infusion Collaborative Director of Clinical Solutions, Bainbridge Health |
National Infusion Collaborative March 2025 Meeting: Evaluating Real-World Infusion Data
The NIC Listserv Is Now Live
